Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06808477 · ClinicalTrials.gov registry record · Phase 1
A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)
A Phase 1 study of Atopic Dermatitis, sponsored by Bambusa Therapeutics.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 198
- Enrollment target
- 7
- Study locations
NCT06808477: Recruiting Phase 1 study of Atopic Dermatitis, sponsored by Bambusa Therapeutics.
NCT06808477 is a Phase 1 study of Atopic Dermatitis that is actively recruiting participants, run by Bambusa Therapeutics. The registered enrollment target is 198 participants, below the 608-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (67% lower). The trial reports 7 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06808477, a Phase 1 study of Atopic Dermatitis, is actively recruiting participants, sponsored by Bambusa Therapeutics.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 198 participants
- Enrollment target
- 7
- Study locations
Study Summary
This is a Phase 1, randomized, blinded, placebo controlled, single ascending dose (SAD) and multiple ascending dose (MAD) study of BBT001 in healthy volunteers (HVs) and adult patients with moderate to severe Atopic Dermatitis (AD).
Primary Outcome
Incidence, relatedness, and severity of adverse events graded per NCI CTCAE v5.0.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG BBT001
Study Locations (7)
Auckland
- Optimal Clinical Trials Central Auckland - Grafton
- Aotearoa Clinical Trials - Otahuhu
- Pacific Clinical Research Network (PCRN) - Auckland - Takapuna
New York
- Equity Medical, LLC - The Bronx
Western Australia
- Linear Clinical Research - Perth
Christchurch
- Optimal Clinical Trials Ltd - Christchurch - Christchurch Central City
Other
- Pacific Clinical Research Network (PCRN) Wellington - Upper Hutt
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 198 participants |
| Start Date | 2025-02-27 |
| Est. Completion | 2027-02-06 |
| Phase | Phase 1 |
What NCT06808477 shows while recruiting
NCT06808477 is an interventional study that assigns participants to a tested intervention. The registered 198 participants enrollment target is mid-sized for trials with a published cap, below the 608-participant average among 150 other Atopic Dermatitis trials with a reported enrollment target (67% lower).
The record links to 1 condition, with Atopic Dermatitis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT06808477 lists 7 locations in 5 states (Auckland, New York, Western Australia).
Frequently Asked Questions
What is clinical trial NCT06808477 about?
NCT06808477 is a clinical study titled "A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)". This is a Phase 1, randomized, blinded, placebo controlled, single ascending dose (SAD) and multiple ascending dose (MAD) study of BBT001 in healthy volunteers (HVs) and adult patients with moderate to severe Atopic Dermatitis (AD).
What is the current status of trial NCT06808477?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 198 participants. The study started on 2025-02-27. Estimated completion is 2027-02-06.
What conditions does trial NCT06808477 study?
This clinical trial studies the following conditions: Atopic Dermatitis.
What interventions are being tested in trial NCT06808477?
The interventions under investigation include: Placebo (DRUG), BBT001 (DRUG).
Who is sponsoring clinical trial NCT06808477?
This trial is sponsored by Bambusa Therapeutics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06808477 being conducted?
This trial has 7 study locations across New York, Western Australia, Auckland, Christchurch. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atopic Dermatitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06808477's enrollment target sits among peer trials
198 63rd of 150 higher than 88 of 150 other Atopic Dermatitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Atopic Dermatitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis
RECRUITING · Phase 1
-
Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)
RECRUITING · Phase 1
-
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
RECRUITING · Phase 1
-
A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis
RECRUITING · Phase 1
-
A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants
ACTIVE NOT RECRUITING · Phase 1
-
Safety, PK, PD, and Clinical Activity of Orally Administered KT-621 in Adult Patients With Atopic Dermatitis (AD)
COMPLETED · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05203328 · 198 participants · NA
Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy
- NCT05426967 · 198 participants · NA
rTMS for Military TBI-related Depression
- NCT05561114 · 198 participants · Phase 3
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus
- NCT05585190 · 198 participants · NA
Stand Up for Your Health with a Sit-stand Desk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI